Free shipping over €250 · Tracked, discreet delivery in Europe

Short bioregulator peptide

Normoftal

Research compoundNot yet reviewedPeptideIn the catalog

In short: A bioregulator peptide associated with retinal tissue in Russian research. The published literature is small and mostly preclinical.

Regulatory status

  1. Cosmetic ingredient
  2. Research compound
  3. In clinical trials
  4. Approved medicine

Not approved as a medicine by the FDA or the EMA. Some are registered in individual countries. Supplied for laboratory research only.

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Common questions

Is Normoftal an approved medicine?

Research compound. Not approved as a medicine by the FDA or the EMA. Some are registered in individual countries. Supplied for laboratory research only.

How much human research is there on Normoftal?

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Does UU supply Normoftal?

Yes, as premium-grade research material for laboratory use. Every batch is tested by an independent lab and the certificate of analysis is published.

More in Brain, mood & sleep

Back to the library
  • Researchuu

    Selank

    Tuftsin analogue

    Early human data
  • Researchuu

    Semax

    ACTH(4-10) analogue

    Mixed evidence
  • Researchuu

    DSIP

    Neuropeptide

    Mixed evidence
  • Researchuu

    Pinealon

    Short bioregulator peptide

    Preclinical
  • Researchuu

    Dihexa

    Angiotensin IV analogue

    Preclinical
  • Researchuu

    ARA-290

    Erythropoietin-derived peptide

    Early human data

The UU library is an educational reference. It is not medical advice, does not make a health claim, and does not tell anyone how to use a compound. UU products are sold for laboratory research use only and are not for human consumption. Regulatory status changes: confirm it with the relevant authority before relying on it.